Patents matching “SION”

US 8765813

Use of treprostinil to treat and prevent ischemic lesions

United Therapeutics Corporation · Granted Jul 1, 2014 · Expires Jun 26, 2034

US 8759301

Gene fusion targeted therapy

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 24, 2014 · Expires Jun 19, 2034

US 8758755

Stem cell fusion model of carcinogenesis

Arizona Board of Regents on Behalf of the University of Arizona · Granted Jun 24, 2014 · Expires Jun 19, 2034

US 8754030

Defensin-antigen fusion proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 17, 2014 · Expires Jun 12, 2034

US 8748114

ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

US 8747872

Nanoemulsion therapeutic compositions and methods of using the same

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 10, 2014 · Expires Jun 5, 2034

US 8741866

Compositions and methods for inhibiting expression of transthyretin

Alnylam Pharmaceuticals, Inc. · Granted Jun 3, 2014 · Expires May 29, 2034

US 8741589

Monitoring two dimensions of diabetes pathogenesis

The Regents of the University of California · Granted Jun 3, 2014 · Expires May 29, 2034

US 8740615

Implant, implant body, and abutment body

Nanto. Precision Co., Ltd · Granted Jun 3, 2014 · Expires May 29, 2034

US 8735369

Compositions and methods for inhibiting expression of a gene from the Ebola virus

The United States of America as represented by the Secretary of the Army · Granted May 27, 2014 · Expires May 22, 2034

US 8735382

Infusion and injection solution of levodopa

Dizlin Medical Design AB · Granted May 27, 2014 · Expires May 22, 2034

CA 2890920

DERIVES DE 1,3-DIHYDROIMIDAZOLE-2-THIONE UTILISABLES DANS LE TRAITEMENT DE L'HYPERTENSION ARTERIELLE PULMONAIRE ET DES LESIONS PULMONAIRES

BIAL PORTELA & Cª S A [PT] · Granted May 22, 2014 · Expires May 17, 2034

US 8728524

Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions

Anika Therapeutics S.r.l. · Granted May 20, 2014 · Expires May 15, 2034

US 8728532

Ischemia/reperfusion protection compositions and methods of using

Regents of the University of Minnesota · Granted May 20, 2014 · Expires May 15, 2034

US 8729037

Method and medicament for inhibiting the expression of a given gene

Alnylam Pharmaceuticals, Inc. · Granted May 20, 2014 · Expires May 15, 2034

US 8722063

Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

The United States of America, as represented by the Secretary of Agriculture · Granted May 13, 2014 · Expires May 8, 2034

US 8712696

Methods of prognosing a rheumatoid arthritis remission phenotype

PROGENIKA BIOPHARMA, S.A. · Granted Apr 29, 2014 · Expires Apr 24, 2034

US 8710031

Compounds for nonsense suppression and methods for their use

PTC THERAPEUTICS, INC. · Granted Apr 29, 2014 · Expires Apr 24, 2034

US 8695119

Coated elastomeric article and method for making a coated elastomeric article

Precision Components, Inc. · Granted Apr 15, 2014 · Expires Apr 10, 2034

US 8697048

Peptide amphiphile suspension to prevent or reduce tumor formation from administered embryonic stem cells

Northwestern University · Granted Apr 15, 2014 · Expires Apr 10, 2034

US 8691786

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

INTEGRATED DNA TECHNOLOGIES, INC. · Granted Apr 8, 2014 · Expires Apr 3, 2034

US 8691872

Dispersions of rasagiline citrate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 8, 2014 · Expires Apr 3, 2034

US 8691967

Multiple promoter expression cassettes for simultaneous delivery of RNAi agents

Benitec, Inc. · Granted Apr 8, 2014 · Expires Apr 3, 2034

US 8685929

Detecting CYP24 expression level as a marker for predisposition to cancer

The Regents of the University of California · Granted Apr 1, 2014 · Expires Mar 27, 2034